...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: About that 18% to 21% RRR...

Take a look at slide #16 of Amarin's presentation.  Our 18 to 21% RRR is actually well ahead of many other cardiovascular disease drugs.  I know this is not an apples to apples comparison...but take it for what it is.

 

https://investor.amarincorp.com/static-files/6eca1aa8-cf50-4d4d-a181-a5202f6942cc

Share
New Message
Please login to post a reply